Bone metastases and skeletal-related events from neuroendocrine tumors (Q34850930)

4 August 2017

Bone metastases and skeletal-related events from neuroendocrine tumors (English)

1 reference

4 August 2017

Katherine Van Loon

1

1 reference

4 August 2017

Li Zhang

2

1 reference

4 August 2017

Jennifer Keiser

3

1 reference

4 August 2017

Cendy Carrasco

4

1 reference

4 August 2017

Katherine Glass

5

1 reference

4 August 2017

Maria-Teresa Ramirez

6

1 reference

4 August 2017

Sarah Bobiak

7

1 reference

4 August 2017

Eric K Nakakura

8

1 reference

4 August 2017

Alan P Venook

9

1 reference

4 August 2017

Manisha H Shah

10

1 reference

4 August 2017

Emily K Bergsland

11

1 reference

4 August 2017

27 November 2014

1 reference

4 August 2017

Endocrine Connections

1 reference

4 August 2017

4

1 reference

4 August 2017

9-17

1 reference

4 August 2017

1

1 reference

Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Skeletal metastasis of carcinoid tumors: Two case reports and review of the literature

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Neuroendocrine tumors of the diffuse neuroendocrine system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Metastatic carcinoid of bone. Report of two cases and review of the literature

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

A Case of a Rectal Carcinoid with Multiple Liver, Lung and Bone Metastases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

99mTc-pyrophosphate bone scans in patients with metastatic carcinoid tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4285767

Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy

9 December 2018

1 reference

12 December 2020

Metastatic carcinoid presenting as a spinal tumor

1 reference

12 December 2020

The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Somatostatin analogue scintigraphy in carcinoid tumours

1 reference

12 December 2020

Identifiers

DOI

10.1530/EC-14-0119

1 reference

4 August 2017

1 reference

4 August 2017

1 reference